重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合糖皮质激素治疗中毒性表皮坏死松解症一例

doi:10.35541/cjd.20190896

Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (4): 356-357.doi: 10.35541/cjd.20190896

• Case Reports • Previous Articles Next Articles

A case of toxic epidermal necrolysis successfully treated with recombinant human tumor necrosis factor-α

Chen Lei, Li Ding, Ma Pingping, Cai Yanxia, Li Jieqing

Department of Dermatovenereology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China

Received:2019-09-11 Revised:2020-04-20 Online:2021-04-15 Published:2021-03-31
Contact: Lei CHEN E-mail:564123654@qq.com

Abstract

Chen Lei, Li Ding, Ma Pingping, Cai Yanxia, Li Jieqing. A case of toxic epidermal necrolysis successfully treated with recombinant human tumor necrosis factor-α [J]. Chinese Journal of Dermatology, 2021, 54(4): 356-357.doi:10.35541/cjd.20190896

［1］	吴志华. 皮肤科治疗学［M］. 3版. 北京: 科学出版社, 2016:113⁃117, 130⁃132.
［2］	张飞. 中毒性表皮坏死松解症发病机制研究进展［J］. 中国麻风皮肤病杂志, 2010,26（7）:499⁃501. doi: 10.3969/j.issn.1009⁃1157.2010.07.017.
［3］	Nassif A, Moslehi H, Le Gouvello S, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis［J］. J Invest Dermatol, 2004,123（5）:850⁃855. doi: 10.1111/j.0022⁃202X. 2004.23439.x.

A case of toxic epidermal necrolysis successfully treated with recombinant human tumor necrosis factor-α

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［3］

Related Articles 0

Metrics

Comments

Recommended 10